Pharm-Olam's response to COVID-19 from CEO Rob Davie, PhD. Read Here

Request a Proposal  

Clinical Trials in Canada: A Separate but Familiar Venue

Sponsors looking for early sites in which to launch Phase I-III trials often turn to the United States, although they can also look to Canada for similar reasons and with equal success. In fact, perhaps Canada’s greatest recommendation as a clinical trial location is that is often cited as the country most like the U.S.; sponsors familiar with operating in the U.S. will find familiar ground in Canada.

Click the image to download the full whitepaper